ETFs Holding RIGL »    RIGL Historical Stock Prices »
RIGL News Video: Thu, Sep 13, 2018, 10:32 AM — Thursday 9/13 Insider Buying Report: KALV, RIGL

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Rigel Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery, developing and providing novel small molecule drugs with immune and hematologic disorders, cancer and rare diseases. Co.'s research focuses on signaling pathways that are critical to disease mechanisms. Co.'s clinical programs include clinical trials of fostamatinib, an oral spleen tyrosine kinase inhibitor, in a number of indications. Self directed investors in Rigel Pharmaceuticals Inc will be interested in keeping up with all Rigel Pharmaceuticals Inc news they can find, both RIGL news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on RIGL. At RediNews, we simplify this task by presenting both RIGL news releases originating from Rigel Pharmaceuticals Inc itself, and RIGL news from a variety of media outlets. Visitors can browse this news online and through our RIGL RSS news feed.


RIGL News — Articles, Videos, & Press Releases

First Week of December 20th Options Trading For Rigel Pharmaceuticals (RIGL)
Monday, April 29, 2019, 10:46 AM — Stock Options Channel
Peek Under The Hood: BIB Has 33% Upside
Thursday, April 25, 2019, 8:11 AM — ETF Channel
Rigel Pharmaceuticals: A 30.9% Better Bargain Than When Mayer III Bought
Tuesday, February 26, 2019, 3:12 PM — Dividend Channel
Top Buys by Top Brass: EVP & Chief Commercial Officer Mayer III's $325.6K Bet on RIGL
Thursday, February 21, 2019, 10:01 AM — Dividend Channel
Peek Under The Hood: XBI Has 52% Upside
Thursday, February 21, 2019, 9:29 AM — ETF Channel
Interesting RIGL Call Options For September 20th
Thursday, January 24, 2019, 11:24 AM — Stock Options Channel
Analysts Predict 20% Gains Ahead For IEIH
Monday, January 21, 2019, 8:42 AM — ETF Channel
Insiders Now Seeing Red With RIGL At New 52-Week Low
Tuesday, December 18, 2018, 4:09 PM — Market News Video
Surprising Analyst 12-Month Target For XBI
Tuesday, December 18, 2018, 9:37 AM — ETF Channel
RIGL: Insiders vs. Shorts
Monday, November 26, 2018, 2:23 PM — Market News Video
XBI's Holdings Imply 80% Gain Potential
Thursday, November 15, 2018, 7:32 AM — ETF Channel
Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 49.5% Annualized Using Options
Tuesday, October 23, 2018, 11:09 AM — Stock Options Channel
How The Pieces Add Up: IWN Headed For $145
Monday, October 15, 2018, 7:44 AM — ETF Channel
The Implied Analyst 12-Month Target For XBI
Friday, September 7, 2018, 8:00 AM — ETF Channel
RIGL: Insiders vs. Shorts
Tuesday, August 28, 2018, 2:27 PM — Market News Video
Top Buys by Directors: Rodriguez's $300K Bet on RIGL
Monday, August 27, 2018, 3:13 PM — Dividend Channel
Top Buys by Top Brass: CEO Rodriguez's $300K Bet on RIGL
Wednesday, August 22, 2018, 10:03 AM — Dividend Channel
How The Pieces Add Up: XBI Headed For $140
Monday, August 6, 2018, 7:47 AM — ETF Channel
First Week of RIGL March 2019 Options Trading
Wednesday, July 25, 2018, 10:44 AM — Stock Options Channel
Investors Snag RIGL 21.5% Lower Than Its Secondary Stock Offering
Monday, July 23, 2018, 10:10 AM — Dividend Channel
Rigel Pharmaceuticals Stock Sees Short Interest Move 34% Higher
Thursday, July 12, 2018, 10:51 AM — Market News Video
Commit To Buy Rigel Pharmaceuticals At $2.50, Earn 22.5% Annualized Using Options
Tuesday, June 5, 2018, 11:50 AM — Stock Options Channel
Peek Under The Hood: PXSG Has 10% Upside
Friday, June 1, 2018, 7:30 AM — ETF Channel
RIGL is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

MYL News
OPK News
ZMH News

RediNews invites you to integrate our free RSS news feeds. While web portal content experience like building out an investor relations web site is a major plus when working with our RSS feeds, you don't need stock quote feed experience to begin working with something as simple as RSS — which stands for Really Simple Syndication. Although such experience could lead to some great custom market content ideas like a custom stock ticker with related news included, you don't need to be at the level of head of IR content for an IR services firm to work with our feeds. And unlike investor relations data feeds that typically carry steep licensing feeds, our RediNews RSS feeds are provided to you free of charge. To give our feeds a try, look for the RSS icon for any news page (which will look like this): .

RIGL News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.